Cargando…
P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials
Autores principales: | Sarzotti-Kelsoe, M, Cox, J, Cleland, N, Denny, T, Hural, J, Needham, L, Ozaki, D, Rodriguez-Chavez, IR, Stevens, G, Stiles, T, Tarragona-Fiol, T, Simkins, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767700/ http://dx.doi.org/10.1186/1742-4690-6-S3-P206 |
Ejemplares similares
-
Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials
por: Sarzotti-Kelsoe, Marcella, et al.
Publicado: (2009) -
Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL)
por: Todd, Christopher A., et al.
Publicado: (2013) -
International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials
por: Ozaki, Daniel A., et al.
Publicado: (2012) -
P06-07. A GCLP accredited Clinical Trial Laboratory Network in Africa and India: a collaborative effort between IAVI and in country research organizations
por: Stevens, G, et al.
Publicado: (2009) -
Validated low-volume aldosterone immunoassay tailored to GCLP-compliant investigations in small sample volumes
por: Schaefer, J., et al.
Publicado: (2017)